Karen E. Joynt Maddox

Karen E. Joynt Maddox

Auto-generated profile, based on publicly available information

Karen E. Joynt Maddox

Washington University School of Medicine, St. Louis, Missouri

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2019 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MBMichael L. Barnett
Michael L. Barnett
AWAndrew Wilcock
Andrew Wilcock
JMJ. Michael McWilliams
J. Michael McWilliams
AEArnold M. Epstein
Arnold M. Epstein
KMKaren E. Joynt Maddox
Karen E. Joynt Maddox
AMAteev Mehrotra
Ateev Mehrotra
In 2016, Medicare implemented Comprehensive Care for Joint Replacement (CJR), a national mandatory bundled-payment model for hip or knee replacement in randomly selected metropolitan statistical areas. Hospitals in such areas receive bonuses or pay penalties based on Medicare spending per hip- or knee-replacement episode (defined as the hospitalization plus 90 days after discharge). We conducted difference-in-differences analyses using Medicare claims from 2015 through 2017, encompassing the first 2 years of bundled payments in the CJR program. We evaluated hip- or knee-replacement episodes in 75 metropolitan statistical areas randomly assigned to mandatory participation in the CJR program (bundled-payment metropolitan statistical areas, hereafter referred to as “treatment” areas) as compared with those in 121 control areas, before and after implementation of the CJR model. The primary outcomes were institutional spending per hip- or knee-replacement episode (i.e., Medicare payments to institutions, primarily to hospitals and post–acute care facilities), rates of postsurgical complications, and the percentage of “high-risk” patients (i.e., patients for whom there was an elevated risk of spending — a measure of patient selection). Analyses were adjusted for the hospital and characteristics of the patients and procedures. From 2015 through 2017, there were 280,161 hip- or knee-replacement procedures in 803 hospitals in treatment areas and 377,278 procedures in 962 hospitals in control areas. After the initiation of the CJR model, there were greater decreases in institutional spending per joint-replacement episode in treatment areas than in control areas (differential change [i.e., the between-group difference in the change from the period before the CJR model], −$812, or a −3.1% differential decrease relative to the treatment-group baseline; P<0.001). The differential reduction was driven largely by a 5.9% relative decrease in the percentage of episodes in which patients were discharged to post–acute care facilities. The CJR program did not have a significant differential effect on the composite rate of complications (P=0.67) or on the percentage of joint-replacement procedures performed in high-risk patients (P=0.81). In the first 2 years of the CJR program, there was a modest reduction in spending per hip- or knee-replacement episode, without an increase in rates of complications. (Funded by the Commonwealth Fund and the National Institute on Aging of the National Institutes of Health.)

1 July 2020 in Stroke
Verified
Journal Article
Closed access
PDF file
GHGmerice Hammond
Gmerice Hammond
ALAlina A. Luke
Alina A. Luke
LELauren Elson
Lauren Elson
ATAmytis Towfighi
Amytis Towfighi
KMKaren E. Joynt Maddox
Karen E. Joynt Maddox
Background and Purpose: The rural-urban life-expectancy gap is widening, but underlying causes are incompletely understood. Prior studies suggest stroke care may be worse for individuals in more rural areas, and technological advancements in stroke care may disproportionately impact individuals in more rural areas. We sought to examine differences and 5-year trends in the care and outcomes of patients hospitalized for stroke across rural-urban strata. Methods: Retrospective cohort study using National Inpatient Sample data from 2012 to 2017. Rurality was classified by county of residence according to the 6-strata National Center for Health Statistics classification scheme. Results: There were 792 054 hospitalizations for acute stroke in our sample. Rural patients were more often white (78% versus 49%), older than 75 (44% versus 40%), and in the lowest quartile of income (59% versus 32%) compared with urban patients. Among patients with acute ischemic stroke, intravenous thrombolysis and endovascular therapy use were lower for rural compared with urban patients (intravenous thrombolysis: 4.2% versus 9.2%, adjusted odds ratio, 0.55 [95% CI, 0.51–0.59], P <0.001; endovascular therapy: 1.63% versus 2.41%, adjusted odds ratio, 0.64 [0.57–0.73], P <0.001). Urban-rural gaps in both therapies persisted from 2012 to 2017. Overall, stroke mortality was higher in rural than urban areas (6.87% versus 5.82%, P <0.001). Adjusted in-patient mortality rates increased across categories of increasing rurality (suburban, 0.97 [0.94–1.0], P =0.086; large towns, 1.05 [1.01–1.09], P =0.009; small towns, 1.10 [1.06–1.15], P <0.001; micropolitan rural, 1.16 [1.11–1.21], P <0.001; and remote rural 1.21 [1.15–1.27], P <0.001 compared with urban patients. Mortality for rural patients compared with urban patients did not improve from 2012 (adjusted odds ratio, 1.12 [1.00–1.26], P <0.001) to 2017 (adjusted odds ratio, 1.27 [1.13–1.42], P <0.001). Conclusions: Rural patients with stroke were less likely to receive intravenous thrombolysis or endovascular therapy and had higher in-hospital mortality than their urban counterparts. These gaps did not improve over time. Enhancing access to evidence-based stroke care may be a target for reducing rural-urban disparities.

1 December 2020 in Medical Care
Verified
Journal Article
Closed access
HTHannah P. Ba Truong
Hannah P. Ba Truong
ALAlina A. Luke
Alina A. Luke
GHGmerice Hammond
Gmerice Hammond
RWRishi K. Md Wadhera
Rishi K. Md Wadhera
MRMat Ma Reidhead
Mat Ma Reidhead
KMKaren E. Joynt Maddox
Karen E. Joynt Maddox
Background: The inclusion of Z-codes for social determinants of health (SDOH) in the 10th revision of the International Classification of Diseases (ICD-10) may offer an opportunity to improve data collection of SDOH, but no characterization of their utilization exists on a national all-payer level. Objective: To examine the prevalence of SDOH Z-codes and compare characteristics of patients with and without Z-codes and hospitals that do and do not use Z-codes. Research Design: Retrospective cohort study using 2016 and 2017 National Inpatient Sample. Participants: Total of 14,289,644 inpatient hospitalizations. Measures: Prevalence of SDOH Z-codes (codes Z55–Z65) and descriptive statistics of patients and hospitals. Results: Of admissions, 269,929 (1.9%) included SDOH Z-codes. Average monthly SDOH Z-code use increased across the study period by 0.01% per month (P<0.001). The cumulative number and proportion of hospitals that had ever used an SDOH Z-code also increased, from 1895 hospitals (41%) in January 2016 to 3210 hospitals (70%) in December 2017. Hospitals that coded at least 1 SDOH Z-code were larger, private not-for-profit, and urban teaching hospitals. Compared with admissions without an SDOH Z-code, admissions with them were for patients who were younger, more often male, Medicaid recipients or uninsured. A higher proportion of admissions with SDOH Z-codes were for mental health (44.0% vs. 3.3%, P<0.001) and alcohol and substance use disorders (9.6% vs. 1.1%, P<0.001) compared with those without. Conclusions: The uptake of SDOH Z-codes has been slow, and current coding is likely poorly reflective of the actual burden of social needs experienced by hospitalized patients.

8 March 2019 in Health Services Research
Verified
Journal Article
Closed access
PDF file
KMKaren E. Joynt Maddox
Karen E. Joynt Maddox
MRMat Reidhead
Mat Reidhead
JHJianhui Hu
Jianhui Hu
AKAmy J. H. Kind
Amy J. H. Kind
AZAlan M. Zaslavsky
Alan M. Zaslavsky
DNDavid R. Nerenz
David R. Nerenz

19 July 2022 in Circulation
Verified
Journal Article
Closed access
PDF file
AKAshley N. Kyalwazi
Ashley N. Kyalwazi
ELEméfah C. Loccoh
Eméfah C. Loccoh
LBLaPrincess C. Brewer
LaPrincess C. Brewer
EOElizabeth O. Ofili
Elizabeth O. Ofili
JXJiaman Xu
Jiaman Xu
RWRishi K. Wadhera
Rishi K. Wadhera
Background: Black adults experience a disproportionately higher burden of cardiovascular risk factors and disease in comparison with White adults in the United States. Less is known about how sex-based disparities in cardiovascular mortality between these groups have changed on a national scale over the past 20 years, particularly across geographic determinants of health and residential racial segregation. Methods: We used CDC WONDER (Centers for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiologic Research) to identify Black and White adults age ≥25 years in the United States from 1999 to 2019. We calculated annual age-adjusted cardiovascular mortality rates (per 100 000) for Black and White women and men, as well as absolute rate differences and rate ratios to compare the mortality gap between these groups. We also examined patterns by US census region, rural versus urban residence, and degree of neighborhood segregation. Results: From 1999 to 2019, age-adjusted mortality rates declined overall for both Black and White adults. There was a decline in age-adjusted cardiovascular mortality among Black (602.1 to 351.8 per 100 000 population) and White women (447.0 to 267.5), and the absolute rate difference (ARD) between these groups decreased over time (1999: ARD, 155.1 [95% CI, 149.9–160.3]; 2019: ARD, 84.3 [95% CI, 81.2–87.4]). These patterns were similar for Black (824.1 to 526.3 per 100 000) and White men (637.5 to 396.0; 1999: ARD, 186.6 [95% CI, 178.6–194.6]; 2019: ARD, 130.3 [95% CI, 125.6–135.0]). Despite this progress, cardiovascular mortality in 2019 was higher for Black women (rate ratio, 1.32 [95% CI, 1.30–1.33])— especially in the younger (age <65 years) subgroup (rate ratio, 2.28 [95% CI, 2.23–2.32])—as well as for Black men (rate ratio, 1.33 [95% CI, 1.32–1.34]), compared with their respective White counterparts. There was regional variation in cardiovascular mortality patterns, and the Black-White gap differed across rural and urban areas. Cardiovascular mortality rates among Black women and men were consistently higher in communities with high levels of racial segregation compared with those with low to moderate levels. Conclusions: During the past 2 decades, age-adjusted cardiovascular mortality declined significantly for Black and White adults in the United States, as did the absolute difference in death rates between these groups. Despite this progress, Black women and men continue to experience higher cardiovascular mortality rates than their White counterparts.

19 July 2018 in New England Journal of Medicine
Verified
Journal Article
Closed access
KMKaren E. Joynt Maddox
Karen E. Joynt Maddox
EOE. John Orav
E. John Orav
JZJie Zheng
Jie Zheng
AEArnold M. Epstein
Arnold M. Epstein
The Center for Medicare and Medicaid Innovation (CMMI) launched the Bundled Payments for Care Improvement (BPCI) initiative in 2013. A subsequent study showed that the initiative was associated with reductions in Medicare payments for total joint replacement, but little is known about the effect of BPCI on medical conditions.